Ads
related to: companies that sell pharmacogenetics testing in californiabd.com has been visited by 10K+ users in the past month
element.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
The company's first scientific instrument, called the PacBio RS, was released to a limited set of customers in late 2010., with full commercial release in early 2011. [ 17 ] [ 8 ] Sequencing provider GATC Biotech was selected by Pacific Biosciences as its first European service provider in late 2010. [ 18 ]
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
Lineagen, Inc. is a privately held personal genomics and biotechnology company based in Salt Lake City, UT. The company was incorporated in 2006 and collaborated with two leading autism research institutions: the University of Utah and The Children's Hospital of Philadelphia (CHOP), to identify novel genetic variants likely causal of autism spectrum disorder.
The company partnered with cities, regions, and states across the United States, setting up and managing different types of testing sites (including drive-through, mobile vans, [61] kiosks, and walkup [62] locations) in an effort to reach general and at-risk populations. As of October 2021, Curative managed 16,557 testing sites nationwide ...
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard .
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. [13] [14] In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Ads
related to: companies that sell pharmacogenetics testing in californiabd.com has been visited by 10K+ users in the past month
element.com has been visited by 10K+ users in the past month